Company
Rarebase
Palo AltoBiotechnologyHealth CareArtificial IntelligenceTherapeuticsDescription
Rarebase, a platform drug development biotechnology company that is revolutionizing discovering and developing medicines at unprecedented speed, scale, and capital efficiency, today announced that Chris Moxham, Ph.D., President and Chief Scientific Officer of Rarebase, has been named Chief Executive Officer effective immediately. Moxham assumes the CEO position from Rarebase co-founder Onno Faber, who has been appointed to the newly created role of Chief Technology Officer.
Quick answer
Rarebase Names Chris Moxham as Chief Executive Officer (October 4, 2023). Rarebase is based in Palo Alto, California, United States.
- What did Rarebase announce on October 4, 2023?
- Rarebase, a platform drug development biotechnology company that is revolutionizing discovering and developing medicines at unprecedented speed, scale, and capital efficiency, today announced that Chris Moxham, Ph.D., President and Chief Scientific Officer of Rarebase, has been named Chief Executive Officer effective immediately. Moxham assumes the CEO position from Rarebase co-founder Onno Faber, who has been...
- What does Rarebase do?
- Rarebase is enabling a better life for the 400 million people living with rare disease.
- Where is Rarebase based?
- Rarebase is based in Palo Alto, California, United States.
- Which similar companies made leadership changes around the same time?
- Kezar Life Sciences (October 3, 2023), Aura Biosciences, Inc. (October 2, 2023), Emmes (October 2, 2023) and Solid Biosciences (October 2, 2023) also announced leadership changes within 45 days of Rarebase.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Kezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer - PharmiWeb.com (October 3, 2023)
- Aura Biosciences Names Hopkins as Chief Medical Officer - MarketWatch (October 2, 2023)
- Emmes Appoints Peter Ronco as Chief Executive Officer (October 2, 2023)
- Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer • Solid Biosciences (October 2, 2023)
- Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer (October 2, 2023)
- Faeth Therapeutics Appoints Debbie Chirnomas, M.D., M.P.H., as Chief Medical Officer - Benzinga (September 29, 2023)
Who to call at Rarebase, and when
A new leader at Rarebase brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Rarebase raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rarebase, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rarebase. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rarebase changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Rarebase changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.